Dear supporters of "Second Opinion: Laetrile At Sloan-Kettering”, It has been many months since the start of this petition, without any sort of response from Sloan-Kettering Cancer Center (they have been hiding this cover-up for over 40 years now). The reason the signature goal for this petition is 43,000 signers -- is because it was 43,000 Americans who petitioned the US Government back in the early 1970's to formally test Laetrile/Amygdalin as an anti-cancer agent. Memorial Sloan-Kettering Cancer Center (MSKCC) was given this task by President Nixon's Cancer Panel - and to everyone's surprise, MSKCC found Laetrile/Amygdalin to stop cancer from spreading 80% of the time, and prevented cancer from starting 80% of the time (compared to control groups) - for 5 years straight in numerous testing models. In light of MSKCC’s continued silence, we’ve decide to offer the entire main feature documentary online for FREE until June 6, 2015. This free screening also includes a statement from the film's director, as well as some added material only found on the DVD and Blu-ray extras. LINK TO FREE SCREENING: https://www.youtube.com/watch?v=HxSIHKynoHY Please share this free screening with everyone you know, an encourage them to sign this petition. In 2014, top research institutions in Germany verified the anti-cancer activity of this substance, and published two studies in the highly respected medical journal "PLOS ONE" (ironically, the Wikipedia editors refuse to allow these verified peer-reviewed published studies within "Amygdalin's" Wikipedia page, citing “these studies go against the negative theme of this entry”). Links to the 2014 German studies: #1: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0105590 #2: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0110244 Science isn’t a practice of negotiation, and MSKCC needs to understand their role: to report honestly on any cancer research within their institution to the public that supports them. It’s very easy MSKCC: come clean. In solidarity, Eric Merola, director: “Second Opinion: Laetrile At Sloan-Kettering”